Correlation Between Passage Bio and Werewolf Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Werewolf Therapeutics, you can compare the effects of market volatilities on Passage Bio and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Werewolf Therapeutics.

Diversification Opportunities for Passage Bio and Werewolf Therapeutics

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Passage and Werewolf is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Passage Bio i.e., Passage Bio and Werewolf Therapeutics go up and down completely randomly.

Pair Corralation between Passage Bio and Werewolf Therapeutics

Given the investment horizon of 90 days Passage Bio is expected to generate 2.71 times less return on investment than Werewolf Therapeutics. In addition to that, Passage Bio is 1.53 times more volatile than Werewolf Therapeutics. It trades about 0.03 of its total potential returns per unit of risk. Werewolf Therapeutics is currently generating about 0.14 per unit of volatility. If you would invest  87.00  in Werewolf Therapeutics on May 1, 2025 and sell it today you would earn a total of  43.00  from holding Werewolf Therapeutics or generate 49.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Passage Bio  vs.  Werewolf Therapeutics

 Performance 
       Timeline  
Passage Bio 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Passage Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Passage Bio reported solid returns over the last few months and may actually be approaching a breakup point.
Werewolf Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Werewolf Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Werewolf Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Passage Bio and Werewolf Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Passage Bio and Werewolf Therapeutics

The main advantage of trading using opposite Passage Bio and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.
The idea behind Passage Bio and Werewolf Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets